u/piotr_bruun

Stretched from seven days to ten to twelve over four months. Appetite told me where the limit was each time.

Is this a pause or a stop? They are different plans.

Aim the stream down the wall of the vial rather than into the cake. Reconstitution is a solubility problem, not a mixing problem, and mechanical shear does nothing helpful.

read the endpoint before you read the headline

I would not compare your numbers to that population. Different baseline, different regimen, different trial.

Certain conditions affect A1c independently of glycaemia. If a result looks inconsistent with the sensor data, that is a question for whoever manages your care rather than for this board.

There is very little published guidance on stopping specifically, which is exactly why board consensus here should carry less weight than usual and a clinician conversation should carry more.

Appetite change and weight change are different measurements on different timescales. The first is usually noticed first and the second lags it.

Correction: that is the oral peptide product, which is a different thing entirely. This one is a small molecule.

Phase 2 or phase 3?

the manufacturing story is genuinely different from the injectables

the boards keep comparing it to injectables at matched doses, which is meaningless

Hair shedding after significant weight loss is a telogen effect that follows the rate of loss.

Adding to this — holding the dose rather than stepping is the option people forget they have.

The effect on gastric emptying is most pronounced early and attenuates with continued dosing, which is the mechanism behind the "it settles at a stable dose" pattern the whole board reports.

Analytically this is a small-molecule identity and purity problem, not a peptide one. The methods, the impurity classes and the reference standards are all different.

The habits are what carried it for a while. When they slipped, everything else followed, in that order.

smaller meals, earlier, is the boring advice that works

Adding more water does not change how much peptide is in the vial. It changes the concentration, which changes the volume you draw for the same amount. That is the entire relationship.

if the maths gives you a fraction of a unit, change the concentration

Push back: an open-label extension tells you about the people who stayed. That is a different question.

If your calculation produces a fraction of a unit, the concentration is wrong for your dose. Change the water volume until the numbers land on whole units.

the first month is a tolerance check, not a results phase

Small fix — the shedding follows the rate of weight loss, not the compound, and it is temporary.

Held the dose for an extra six weeks instead of stepping. The fatigue settled and I lost the same amount anyway.

Milligram-for-milligram comparison with an injectable peptide is not meaningful and I should not have made it.

Went looking for independent testing on this and found essentially nothing, which was clarifying.

Correction: that gives 20 units, not what you have written. 5mg into 2mL is 2.5mg/mL and the division follows from there.

Show the arithmetic — where did the unit figure come from?

I keep a laminated card in the drawer with the arithmetic on it. Looks ridiculous. Has never once let me draw the wrong volume.

What else is in the regimen?

What did the confidence interval look like?

Which country?

Adding the one habit worth starting today: write the concentration on the vial.

Small fix — you have described interval stretching and called it a taper. The exposure profiles differ.

That symptom is not the one being described upthread. Two different things with similar names and the answers are not interchangeable.